Premarket Decliner
IKT Inhibikase Therapeutics4.03-0.83-17.0%
Premarket:3.07-0.96 (-23.9%)
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
PRNewswireTue, 15-Jun 7:41 PM
